Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 379

1.

The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.

Foulds J.

Int J Clin Pract. 2006 May;60(5):571-6. Review.

PMID:
16700857
[PubMed - indexed for MEDLINE]
2.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
[PubMed - indexed for MEDLINE]
3.

Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.

Hays JT, Ebbert JO.

Drugs. 2010 Dec 24;70(18):2357-72. doi: 10.2165/11538190-000000000-00000. Review.

PMID:
21142259
[PubMed - indexed for MEDLINE]
4.

Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.

Tonstad S.

J Cardiovasc Nurs. 2006 Nov-Dec;21(6):433-6.

PMID:
17293731
[PubMed - indexed for MEDLINE]
5.

Varenicline: for smoking cessation.

Rao J, Shankar PK.

Kathmandu Univ Med J (KUMJ). 2009 Apr-Jun;7(26):162-4. Review.

PMID:
20071853
[PubMed - indexed for MEDLINE]
6.

Efficacy and safety of varenicline for smoking cessation.

Hays JT, Ebbert JO, Sood A.

Am J Med. 2008 Apr;121(4 Suppl 1):S32-42. doi: 10.1016/j.amjmed.2008.01.017. Review.

PMID:
18342165
[PubMed - indexed for MEDLINE]
7.

Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?

Doggrell SA.

Expert Opin Pharmacother. 2007 Dec;8(17):2903-15. Review.

PMID:
18001252
[PubMed - indexed for MEDLINE]
8.

Nicotine dependence and smoking cessation.

Tan L, Tang Q, Hao W.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Nov;34(11):1049-57. Review.

PMID:
19952392
[PubMed - indexed for MEDLINE]
Free Article
9.

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.

West R, Baker CL, Cappelleri JC, Bushmakin AG.

Psychopharmacology (Berl). 2008 Apr;197(3):371-7. Epub 2007 Dec 15.

PMID:
18084743
[PubMed - indexed for MEDLINE]
10.

A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.

Tsai ST, Cho HJ, Cheng HS, Kim CH, Hsueh KC, Billing CB Jr, Williams KE.

Clin Ther. 2007 Jun;29(6):1027-39.

PMID:
17692719
[PubMed - indexed for MEDLINE]
11.
12.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
[PubMed - indexed for MEDLINE]
13.

Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

Cahill K, Stevens S, Perera R, Lancaster T.

Cochrane Database Syst Rev. 2013 May 31;5:CD009329. doi: 10.1002/14651858.CD009329.pub2. Review.

PMID:
23728690
[PubMed - indexed for MEDLINE]
14.

[New drugs; varenicline].

van Bronswijk H, Dubois EA, Zitman FG, Cohen AF.

Ned Tijdschr Geneeskd. 2007 Nov 10;151(45):2503-4. Dutch.

PMID:
18062594
[PubMed - indexed for MEDLINE]
15.

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.

Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR.

Arch Intern Med. 2006 Aug 14-28;166(15):1561-8.

PMID:
16908788
[PubMed - indexed for MEDLINE]
16.

Pharmacotherapy for tobacco dependence.

Fant RV, Buchhalter AR, Buchman AC, Henningfield JE.

Handb Exp Pharmacol. 2009;(192):487-510. doi: 10.1007/978-3-540-69248-5_17. Review.

PMID:
19184660
[PubMed - indexed for MEDLINE]
17.

Varenicline: progress in smoking cessation treatment.

Glover ED, Rath JM.

Expert Opin Pharmacother. 2007 Aug;8(11):1757-67. Review.

PMID:
17685891
[PubMed - indexed for MEDLINE]
18.

Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.

Rollema H, Coe JW, Chambers LK, Hurst RS, Stahl SM, Williams KE.

Trends Pharmacol Sci. 2007 Jul;28(7):316-25. Epub 2007 Jun 18. Review.

PMID:
17573127
[PubMed - indexed for MEDLINE]
19.

Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.

Lam S, Patel PN.

Cardiol Rev. 2007 May-Jun;15(3):154-61. Review.

PMID:
17438382
[PubMed - indexed for MEDLINE]
20.

[Current and future medical drugs for smoking cessation].

Kusma B, Mache S, Deissenrieder F, Quarcoo D, Welte T, Groneberg D.

Laryngorhinootologie. 2009 Jun;88(6):410-9; quiz 420-2. doi: 10.1055/s-0029-1220929. Epub 2009 Jun 5. German.

PMID:
19504411
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk